These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10051823)

  • 1. [Use of driptan (oxybutinin) in patients with urgent forms of urination disorders].
    Loran OB; Pushkar' DIu; Tevlin KP
    Urol Nefrol (Mosk); 1998; (6):24-6. PubMed ID: 10051823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride.
    Bary PR; Moisey CU; Stephenson TP; Brendler CB
    Prog Clin Biol Res; 1981; 78():313-9. PubMed ID: 7038709
    [No Abstract]   [Full Text] [Related]  

  • 3. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders].
    De Grazia E; Cimador M
    Minerva Pediatr; 1999 May; 51(5):149-52. PubMed ID: 10479880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effects of intrarectal administration of oxybutynin].
    Radziszewski P; Borkowski A
    Wiad Lek; 2002; 55(11-12):691-8. PubMed ID: 12715351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urge incontinence in elderly people: factors predicting the severity of urine loss before and after pharmacological treatment.
    Griffiths DJ; McCracken PN; Harrison GM; Moore KN
    Neurourol Urodyn; 1996; 15(1):53-7. PubMed ID: 8696356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The usefulness of micturition flow acceleration in the diagnosis of bladder instability].
    Salinas Casado J; Prieto Chaparro L; Martín Garcia C; Rapariz González M; Virseda Chamorro M; Nacarino Corbacho L; Resel Estévez L
    Arch Esp Urol; 1993 Dec; 46(10):891-5. PubMed ID: 7511367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined treatment of patients with detrusor instability].
    Al-Shukri SKh; Kuz'min IV; Amdiĭ RE
    Urologiia; 2001; (5):26-9. PubMed ID: 11641975
    [No Abstract]   [Full Text] [Related]  

  • 11. Detrol LA and Diropan XL for overactive bladder.
    Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical treatment of bladder instability. Our experience].
    Zubiaur Líbano C; Loizaga Iriarte A; Ullate Jaime V; García Sastre E; Arciniega García JM; Infante Riaño R; Flores Corral N
    Arch Esp Urol; 1997; 50(6):633-42. PubMed ID: 9412364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence].
    Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Hisazumi H
    Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monosymptomatic nocturnal enuresis: disease or complaint?].
    Otto-Buczkowska E; Szirer G
    Wiad Lek; 2000; 53(3-4):185-90. PubMed ID: 10946607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal oxybutynin (oxytrol) for urinary incontinence.
    Dull P
    Am Fam Physician; 2004 Dec; 70(12):2351-2. PubMed ID: 15617300
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxybutinin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trial.
    Holmes DM; Montz FJ; Stanton SL
    Br J Obstet Gynaecol; 1989 May; 96(5):607-12. PubMed ID: 2667633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in anticholinergic therapy delivery systems.
    Davila GW
    Geriatrics; 2002 May; 57 Suppl 1():29-34. PubMed ID: 12040601
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of detrusor instability.
    Eckford SD; Keane DP
    Br J Hosp Med; 1993 Feb 17-Mar 2; 49(4):282-5. PubMed ID: 8443630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oxybutynin treatment on cognition in children with diurnal incontinence.
    Sommer BR; O'Hara R; Askari N; Kraemer HC; Kennedy WA
    J Urol; 2005 Jun; 173(6):2125-7. PubMed ID: 15879864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous administration rather than swallowing].
    Schubert-Zsilavecz M
    Krankenpfl J; 2005; 43(7-10):186. PubMed ID: 16515258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.